Insmed Lung Infection Therapy Data Impresses, Analyst Sees Approval Path

Symptom Score Gains And Durable Culture ConversionThe ENCORE study’s results indicate that Arikayce (amikacin liposome inhalation suspension), in combination with a multidrug therapy, met its primary and all secondary endpoints, showcasing its potential to benefit patients with Mycobacterium avium complex lung infections.MAC lung infection is a chronic, often indolent respiratory illness caused by environmental bacteria (soil/water).The study met primary and all multiplicity-controlled secondary culture con ...